The question is more urgent as over-the-counter continuous glucose monitoring devices become more widely available.

We recently published a list of the 10 Worst Performing Stocks in S&P 500 in 2024. In this article, we are going to take a ...

Medicare's decision to reimburse for the G6 and G7 is a favorable development ... which involves integrating Dexcom’s CGM with an insulin pump) moves the CGM technology one step closer to ...

DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose Monitoring (CGM) System is being worn by astronauts ...

DexCom is a pioneer in the development of continuous glucose monitoring (CGM) systems, which are used by people managing diabetes. Its innovative devices like the G6 and G7 have set the standard ...

Personal stories of people using one CGM system or another are only anecdotal ... has to pay for FreeStyle Libre - in comparison to Dexcom's G6 (or G7) and also in comparison to Medtronic's ...

StockNews.com lowered shares of DexCom (NASDAQ:DXCM – Free Report) from a buy rating to a hold rating in a research report report published on Saturday. A number of other analysts have also weighed in ...

Equities researchers at Leerink Partnrs lowered their FY2026 earnings per share (EPS) estimates for DexCom in a research ...

DexCom, Inc. DXCM is scheduled to release ... global awareness about the benefits of DXCM’s real-time Continuous Glucose Monitoring (“CGM”) system. Potential robust contributions from ...

Jefferies analyst Matthew Taylor maintained a Buy rating on Dexcom (DXCM – Research Report) today and set a price target of $100.00. The ...